Jeifer Biotech's research platform is equipped with the most advanced facilities, emphasizing the development of three main pillars, including high-performance liquid chromatography systems, biocatalytic laboratories, and impurity measurement stations.
1. Green synthesis optimization: Develop a steroid production method with a low carbon footprint and minimal environmental damage.
2. Create ultra-pure formulas: Improve impurity control to meet the needs of precision medicine and pediatric care.
3. Enhance stability and bioavailability: Advanced crystallization and formulation technologies enable clinical applications worldwide, increasing the solubility and shelf life of drugs.
Our research platform has built a seamlessly-connected interdisciplinary collaborative R&D system, which integrates the professional forces of R&D, production, and clinical teams. It combines chemical synthesis and biological manufacturing technologies to break through the technical bottlenecks in steroid API production. Also, it provides customized R&D support for global partners according to regional regulatory and clinical requirements. This way, it can achieve rapid iteration of new processes and speed up the market launch of high-performance products.
The platform focuses on the core of clinical value, deepens the connection between the laboratory R&D of steroid APIs and clinical applications. It conducts reverse R&D based on clinical demand data to optimize the performance of APIs in specific disease treatment scenarios. It also delves into the research on formulations for special populations to improve the suitability of steroid drugs for the elderly and children. Moreover, it cooperates closely with clinical institutions to verify the practical application effects of new APIs and provide professional support for the collection of clinical trial data.
As an important bridge for the integration of industry, academia, and research, the research platform has co-established joint R&D centers with top universities and research institutions to explore cutting-edge biomanufacturing technologies in the steroid field. It also promotes the transformation of laboratory innovation results into industrial production processes to commercialize the value of technologies. Meanwhile, it shares technological research results and industry data with the pharmaceutical industry to help upgrade the global R&D standards for steroid APIs.
Providing high-quality chemical products and logistics solutions for global trade partners.
